Cargando…
Activated microglia mediate synapse loss and short-term memory deficits in a mouse model of transthyretin-related oculoleptomeningeal amyloidosis
Oculoleptomeningeal amyloidosis (OA) is a fatal and untreatable hereditary disease characterized by the accumulation of transthyretin (TTR) amyloid within the central nervous system. The mechanisms underlying the pathogenesis of OA, and in particular how amyloid triggers neuronal damage, are still u...
Autores principales: | Azevedo, E P, Ledo, J H, Barbosa, G, Sobrinho, M, Diniz, L, Fonseca, A C C, Gomes, F, Romão, L, Lima, F R S, Palhano, F L, Ferreira, S T, Foguel, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789183/ https://www.ncbi.nlm.nih.gov/pubmed/24008733 http://dx.doi.org/10.1038/cddis.2013.325 |
Ejemplares similares
-
Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient
por: McColgan, P., et al.
Publicado: (2014) -
Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
por: Law, Steven, et al.
Publicado: (2020) -
Transthyretin cardiac amyloidosis
por: Tomoaia, Raluca, et al.
Publicado: (2021) -
Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022) -
Liver‐directed drugs for transthyretin‐mediated amyloidosis
por: Brannagan, Thomas H., et al.
Publicado: (2022)